help button home button Am J Pathol Epitomics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galiano, R. D.
Right arrow Articles by Gurtner, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galiano, R. D.
Right arrow Articles by Gurtner, G. C.
(American Journal of Pathology. 2004;164:1935-1947.)
© 2004 American Society for Investigative Pathology

Topical Vascular Endothelial Growth Factor Accelerates Diabetic Wound Healing through Increased Angiogenesis and by Mobilizing and Recruiting Bone Marrow-Derived Cells

Robert D. Galiano*, Oren M. Tepper*, Catherine R. Pelo*, Kirit A. Bhatt*, Matthew Callaghan*, Nicholas Bastidas*, Stuart Bunting{dagger}, Hope G. Steinmetz{dagger} and Geoffrey C. Gurtner*

From the Laboratory for Microvascular Research and Vascular Tissue Engineering,*New York University School of Medicine, New York, New York; and the Department of Physiology,{dagger}Genentech, South San Francisco, California

Diminished production of vascular endothelial growth factor (VEGF) and decreased angiogenesis are thought to contribute to impaired tissue repair in diabetic patients. We examined whether recombinant human VEGF165 protein would reverse the impaired wound healing phenotype in genetically diabetic mice. Paired full-thickness skin wounds on the dorsum of db/db mice received 20 µg of VEGF every other day for five doses to one wound and vehicle (phosphate-buffered saline) to the other. We demonstrate significantly accelerated repair in VEGF-treated wounds with an average time to resurfacing of 12 days versus 25 days in untreated mice. VEGF-treated wounds were characterized by an early leaky, malformed vasculature followed by abundant granulation tissue deposition. The VEGF-treated wounds demonstrated increased epithelialization, increased matrix deposition, and enhanced cellular proliferation, as assessed by uptake of 5-bromodeoxyuridine. Analysis of gene expression by real-time reverse transcriptase-polymerase chain reaction demonstrates a significant up-regulation of platelet-derived growth factor-B and fibroblast growth factor-2 in VEGF-treated wounds, which corresponds with the increased granulation tissue in these wounds. These experiments also demonstrated an increase in the rate of repair of the contralateral phosphate-buffered saline-treated wound when compared to wounds in diabetic mice never exposed to VEGF (18 days versus 25 days), suggesting that topical VEGF had a systemic effect. We observed increased numbers of circulating VEGFR2+/CD11b cells in the VEGF-treated mice by fluorescence-activated cell sorting analysis, which likely represent an endothelial precursor population. In diabetic mice with bone marrow replaced by that of tie2/lacZ mice we demonstrate that the local recruitment of bone marrow-derived endothelial lineage lacZ+ cells was augmented by topical VEGF. We conclude that topical VEGF is able to improve wound healing by locally up-regulating growth factors important for tissue repair and by systemically mobilizing bone marrow-derived cells, including a population that contributes to blood vessel formation, and recruiting these cells to the local wound environment where they are able to accelerate repair. Thus, VEGF therapy may be useful in the treatment of diabetic complications characterized by impaired neovascularization.





This article has been cited by other articles:


Home page
JDRHome page
S. Guo and L.A. DiPietro
Factors Affecting Wound Healing
Journal of Dental Research, March 1, 2010; 89(3): 219 - 229.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
S. Roy, K. Trudeau, S. Roy, Y. Behl, S. Dhar, and A. Chronopoulos
New Insights into Hyperglycemia-induced Molecular Changes in Microvascular Cells
Journal of Dental Research, February 1, 2010; 89(2): 116 - 127.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Li, D. M. Danilenko, S. Bunting, R. Ganesan, S. Sa, R. Ferrando, T. D. Wu, G. A. Kolumam, W. Ouyang, and D. Kirchhofer
The Serine Protease Marapsin Is Expressed in Stratified Squamous Epithelia and Is Up-regulated in the Hyperproliferative Epidermis of Psoriasis and Regenerating Wounds
J. Biol. Chem., January 2, 2009; 284(1): 218 - 228.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
G.-J. Wang, X.-K. Li, K. Sakai, and Lu Cai
Low-dose radiation and its clinical implications: diabetes
Human and Experimental Toxicology, February 1, 2008; 27(2): 135 - 142.
[Abstract] [PDF]


Home page
Diabetes CareHome page
S. T.M. Krishnan, C. Quattrini, M. Jeziorska, R. A. Malik, and G. Rayman
Neurovascular Factors in Wound Healing in the Foot Skin of Type 2 Diabetic Subjects
Diabetes Care, December 1, 2007; 30(12): 3058 - 3062.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S.-J. Byun, K.-S. Choi, S. H. Park, N. W. Cho, C. Hyun Yoo, K. J. Yun, Y. J. Koh, G. Y. Koh, B. J. So, and K.-H. Yoon
Cartilage Oligometric Matrix Protein-Angiopoietin-1 Promotes Revascularization Through Increased Survivin Expression in Dermal Endothelial Cells of Skin Grafts in Mice
Am. J. Pathol., November 1, 2007; 171(5): 1682 - 1690.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Caballero, N. Sengupta, A. Afzal, K.-H. Chang, S. Li Calzi, D. L. Guberski, T. S. Kern, and M. B. Grant
Ischemic Vascular Damage Can Be Repaired by Healthy, but Not Diabetic, Endothelial Progenitor Cells
Diabetes, April 1, 2007; 56(4): 960 - 967.
[Abstract] [Full Text] [PDF]


Home page
INT J LOW EXTREM WOUNDSHome page
N. Papanas and E. Maltezos
Growth Factors in the Treatment of Diabetic Foot Ulcers: New Technologies, Any Promises?
International Journal of Lower Extremity Wounds, March 1, 2007; 6(1): 37 - 53.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. C. Schatteman, M. Dunnwald, and C. Jiao
Biology of bone marrow-derived endothelial cell precursors
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H1 - H18.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Cianfarani, G. Zambruno, L. Brogelli, F. Sera, P. M. Lacal, M. Pesce, M. C. Capogrossi, C. M. Failla, M. Napolitano, and T. Odorisio
Placenta Growth Factor in Diabetic Wound Healing: Altered Expression and Therapeutic Potential
Am. J. Pathol., October 1, 2006; 169(4): 1167 - 1182.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Andrassy, J. Igwe, F. Autschbach, C. Volz, A. Remppis, M. F. Neurath, E. Schleicher, P. M. Humpert, T. Wendt, B. Liliensiek, et al.
Posttranslationally Modified Proteins as Mediators of Sustained Intestinal Inflammation
Am. J. Pathol., October 1, 2006; 169(4): 1223 - 1237.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Saaristo, T. Tammela, A. Farkkila, M. Karkkainen, E. Suominen, S. Yla-Herttuala, and K. Alitalo
Vascular Endothelial Growth Factor-C Accelerates Diabetic Wound Healing
Am. J. Pathol., September 1, 2006; 169(3): 1080 - 1087.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
L. Pardanaud and A. Eichmann
Identification, emergence and mobilization of circulating endothelial cells or progenitors in the embryo
Development, July 1, 2006; 133(13): 2527 - 2537.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
G. T. Richter, C. Y. Fan, O. Ozgursoy, J. McCoy, and E. Vural
Effect of Vascular Endothelial Growth Factor on Skin Graft Survival in Sprague-Dawley Rats.
Arch Otolaryngol Head Neck Surg, June 1, 2006; 132(6): 637 - 641.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C.-H. Cho, H.-K. Sung, K.-T. Kim, H. G. Cheon, G. T. Oh, H. J. Hong, O.-J. Yoo, and G. Y. Koh
COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model
PNAS, March 28, 2006; 103(13): 4946 - 4951.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. Roth, M. Piekarek, M. Paulsson, H. Christ, T. Krieg, W. Bloch, J. M. Davidson, and S. A. Eming
Plasmin Modulates Vascular Endothelial Growth Factor-A-Mediated Angiogenesis during Wound Repair
Am. J. Pathol., February 1, 2006; 168(2): 670 - 684.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. A. Wilgus, A. M. Matthies, K. A. Radek, J. V. Dovi, A. L. Burns, R. Shankar, and L. A. DiPietro
Novel Function for Vascular Endothelial Growth Factor Receptor-1 on Epidermal Keratinocytes
Am. J. Pathol., November 1, 2005; 167(5): 1257 - 1266.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Simons
Angiogenesis, Arteriogenesis, and Diabetes: Paradigm Reassessed?
J. Am. Coll. Cardiol., September 6, 2005; 46(5): 835 - 837.
[Full Text] [PDF]


Home page
DiabetesHome page
J. Chen, M. Kasper, T. Heck, K. Nakagawa, P. M. Humpert, L. Bai, G. Wu, Y. Zhang, T. Luther, M. Andrassy, et al.
Tissue Factor as a Link Between Wounding and Tissue Repair
Diabetes, July 1, 2005; 54(7): 2143 - 2154.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
K Gupta and J Zhang
Angiogenesis: a curse or cure?
Postgrad. Med. J., April 1, 2005; 81(954): 236 - 242.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Frantz, K. A. Vincent, O. Feron, and R. A. Kelly
Innate Immunity and Angiogenesis
Circ. Res., January 7, 2005; 96(1): 15 - 26.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society for Investigative Pathology.